The incidence and risk factors of hyperprogressive disease(HPD) in non-small cell lung cancer(NSCLC) treated with immune checkpoint inhibitors(ICI)Hyeonseon Kim,Yeun Ho Lee,Chiwoo Song,Leeseul Kim,Min Jeong Kim,Horyun Choi,Jinah Kim,Young Kwang ChaeCANCER RESEARCH(2022)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要